Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 42.63% on an annualized basis producing an average annual return of 56.65%. Currently, Viking Therapeutics has a market capitalization of $6.92 billion.
Buying $1000 In VKTX: If ...